Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Nathan Segall, MD
Clinical Research Atlanta
Disclosure(s): No financial relationships to disclose
Poster(s):
2134 - A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a
Group B Streptococcus
6-Valent Polysaccharide Conjugate Vaccine (GBS6)
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET